Michael J. Seminerio

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio et al. · The Journal of Headache and Pain · 2020 · 129 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo

Matthew J. Robson, Meenal Elliott, Michael J. Seminerio et al. · European Neuropsychopharmacology · 2011 · 91 citations

Medicine, Neuroscience, Pharmacology +12

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

Richard B. Lipton, Joshua M. Cohen, Maja Galić et al. · Headache The Journal of Head and Face Pain · 2021 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo

Sebastiano Intagliata, Abhisheak Sharma, Tamara I. King et al. · The AAPS Journal · 2020 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine

Maurice T. Driessen, Joshua M. Cohen, Stephen F. Thompson et al. · The Journal of Headache and Pain · 2022 · 44 citations · Full text

Medicine, Neurology, Pharmacotherapy +16